Skip to Content

CNN – Health

The Omicron coronavirus variant partly escapes the protection offered by the Pfizer vaccine

Omicron coronavirus variant partly evades Pfizer vaccine’s protection, study shows

By Maggie Fox, CNN The Omicron coronavirus variant partly escapes the protection offered by the Pfizer vaccine, but people who have been previously infected and then vaccinated are likely to be well protected, researchers working in South Africa reported Tuesday. Boosters are also likely to protect people, Alex Sigal of the Africa Health Research Institute

Continue Reading
A 7 year-old child holds a sticker she received after getting the Pfizer-BioNTech Covid-19 vaccine at the Child Health Associates office in Novi

Some teens may get a Covid-19 vaccine booster soon, but younger kids might not get one at all

By Jen Christensen, CNN As more young children are getting their second doses of Covid-19 vaccine, another question is popping up: When will kids and younger teens need a booster shot? Dr. Sean O’Leary, a professor of pediatric infectious disease at the University of Colorado School of Medicine who works with Children’s Hospital Colorado, said

Continue Reading
A new study published  in the journal Circulation

Blood pressure climbed during coronavirus pandemic, especially among women, study suggests

By Jacqueline Howard, CNN US adults — especially women — have seen a rise in blood pressure during the coronavirus pandemic, a new study suggests. The study, published Monday in the journal Circulation, included data on 464,585 employees and their spouses or partners from several different companies who participated in employer-sponsored wellness programs by Quest

Continue Reading

Mix-and-match J&J Covid booster raised immune response after Pfizer vaccine, study finds

By Maggie Fox, CNN Using the Johnson & Johnson vaccine as a booster for people initially immunized with the Pfizer/BioNTech vaccine produces a strong immune response and may do more to elicit protection against severe disease, researchers reported Sunday. Their small study of 65 volunteers who all initially got two doses of Pfizer/BioNTech’s vaccine showed

Continue Reading
Skip to content